Anna University, Chennai, will release the syllabus for the TANCET MBA 2026 exam along with the information bulletin on its ...

Bristol Myers Squibb and Johnson & Johnson have said they will stop development of their oral Factor XIa inhibitor milvexian in acute coronary syndrome after a disappointing trial result. The decision ...

HHS’s move Monday to overhaul the childhood vaccine schedule without public input marks Health Secretary Robert F. Kennedy Jr ...

KUALA LUMPUR: BMS Holdings Bhd made a lacklustre debut on the ACE Market of Bursa Malaysia today, opening below its initial public offering (IPO) price of 22 sen per share. The Johor-based building ...

Ahmedabad: The All India Council for Technical Education (AICTE) has officially announced the commencement of the application process for the approval of new institutions, an increase in intake, the ...

KUALA LUMPUR: BMS Holdings Bhd, which is set to list on the ACE Market of Bursa Malaysia Securities on Dec 8, saw the public portion of its initial public offering (IPO) subscribed 2.40 times. The ...

The Maharashtra State Common Entrance Test (CET) Cell on Monday announced that from the academic year 2026-27, a single Common Entrance Test (CET) will be conducted for BHMCT and BCA, BBA, BMS and BBM ...

FRANKFURT, Nov 3 (Reuters) - Germany's BioNTech (22UAy.DE), opens new tab on Monday lifted its 2025 revenue guidance after receiving initial payments from its new partner Bristol Myers Squibb (BMY.N), ...

Each programme has been designed to provide hands-on learning through real-world applications. The Ministry of Education (MoE) is offering five free Artificial Intelligence (AI) courses on the SWAYAM ...

Maharashtra faces a 65% vacancy in professional course admissions due to delayed CETs, with only 36,812 of 1,05,061 seats filled so far. MUMBAI: Admissions to undergraduate professional courses such ...

In 2024, Ritambhara Vishva Vidyapeeth, an educational trust in suburban Juhu, that manages the Malini Kishor Sanghvi College of Commerce and Economics, asked the AICTE if they could initiate a BMS ...

Bristol Myers Squibb is securing an opportunity to compete in the next generation of cell therapies through the $1.5 billion acquisition of Orbital Therapeutics, a startup with a lead program nearing ...